Fullcast Holdings Co., Ltd. (4848.T)
JPY 1436.0
(-1.03%)
JPY 1436.0
(-1.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.16 Billion | 6.79 Billion | 6.36 Billion | 3.97 Billion | 5.4 Billion | 4.47 Billion |
| Net Income | 5.89 Billion | 9.92 Billion | 7.6 Billion | 6.36 Billion | 7.13 Billion | 5.3 Billion |
| Depreciation & Amortization | 748 Million | 392 Million | 426 Million | 469 Million | 473 Million | 384 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -25 Million | -475 Million | -598 Million | -1 Million | -33 Million | -232 Million |
| Other non-cash items | -1.45 Billion | -3.04 Billion | -1.06 Billion | -2.84 Billion | -2.16 Billion | -979 Million |
| Investing Cash Flow | -6.36 Billion | -958 Million | -99 Million | -89 Million | 8 Million | -2.87 Billion |
| Investments in PPE | -299 Million | -284 Million | -179 Million | -279 Million | -434 Million | -298 Million |
| Acquisitions | -7.69 Billion | -838 Million | 45 Million | -251 Million | 165 Million | -423 Million |
| Investment purchases | -98 Million | -13 Million | -127 Million | -111 Million | -43 Million | -2.21 Billion |
| Sales/Maturities of investments | 1.5 Billion | 186 Million | 20 Million | 433 Million | 107 Million | 10 Million |
| Other Investing Activities | 222 Million | -9 Million | 142 Million | 119 Million | 213 Million | 52 Million |
| Financing Cash Flow | -4.95 Billion | -2.62 Billion | -2.16 Billion | -2.47 Billion | -2.07 Billion | -2.5 Billion |
| Debt repayment | -604 Million | -46 Million | -80 Million | - | -192 Million | -762 Million |
| Dividends payments | -2.29 Billion | -1.66 Billion | -1.57 Billion | -1.47 Billion | -1.38 Billion | -1.05 Billion |
| Common Stock Repurchased | -2.02 Billion | -907 Million | -554 Million | -995 Million | -847 Million | -685 Million |
| Common Stock Issuance | 1 Million | - | - | - | 310 Million | - |
| Other Financing Activities | -30 Million | -2 Million | 37 Million | -1 Million | 37 Million | -5 Million |
| Accounts receivables | 106 Million | -1.77 Billion | -1.32 Billion | 88 Million | -569 Million | -595 Million |
| Accounts payables | -204 Million | 310 Million | 341 Million | -117 Million | -95 Million | 213 Million |
| Inventory | - | -17 Million | 3 Million | 23 Million | 11 Million | -22 Million |
| Other working capital | 73 Million | 1.01 Billion | 387 Million | 5 Million | 620 Million | -210 Million |
| Cash at beginning of period | 20.62 Billion | 17.41 Billion | 13.3 Billion | 11.81 Billion | 8.46 Billion | 9.37 Billion |
| Cash at end of period | 14.46 Billion | 20.62 Billion | 17.41 Billion | 13.3 Billion | 11.81 Billion | 8.46 Billion |
| Capital Expenditure | -299 Million | -284 Million | -179 Million | -279 Million | -434 Million | -298 Million |
| Effect of forex changes on cash | -1 Million | - | - | 80 Million | 1 Million | - |
| Net cash flow / Change in cash | -6.15 Billion | 3.21 Billion | 4.1 Billion | 1.49 Billion | 3.34 Billion | -904 Million |
| Free Cash Flow | 4.86 Billion | 6.51 Billion | 6.18 Billion | 3.7 Billion | 4.97 Billion | 4.17 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.32 Billion | 2.2 Billion | 5.89 Billion | 1.32 Billion | 1.36 Billion | 1.62 Billion |
| Depreciation & Amortization | - | - | 748 Million | 467 Million | 209 Million | 182 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -25 Million | - | - | - |
| Other non-cash items | -1.32 Billion | -2.2 Billion | -1.45 Billion | -1.32 Billion | -1.36 Billion | -1.62 Billion |
| Investing Cash Flow | - | - | -6.36 Billion | - | - | - |
| Investments in PPE | - | - | -299 Million | - | - | - |
| Acquisitions | - | - | -7.69 Billion | - | - | - |
| Investment purchases | - | - | -98 Million | - | - | - |
| Sales/Maturities of investments | - | - | 1.5 Billion | - | - | - |
| Other Investing Activities | - | - | 222 Million | - | - | - |
| Financing Cash Flow | - | - | -4.95 Billion | - | - | - |
| Debt repayment | - | - | -604 Million | - | - | - |
| Dividends payments | - | - | -2.29 Billion | - | - | - |
| Common Stock Repurchased | - | - | -2.02 Billion | - | - | - |
| Common Stock Issuance | - | - | 1 Million | - | - | - |
| Other Financing Activities | - | - | -30 Million | - | - | - |
| Accounts receivables | - | - | 106 Million | - | - | - |
| Accounts payables | - | - | -204 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 73 Million | - | - | - |
| Cash at beginning of period | - | - | 20.62 Billion | 15.76 Billion | 15.45 Billion | 19.38 Billion |
| Cash at end of period | - | - | 14.46 Billion | 14.46 Billion | 15.76 Billion | 15.45 Billion |
| Capital Expenditure | - | - | -299 Million | - | - | - |
| Effect of forex changes on cash | - | - | -1 Million | - | - | - |
| Net cash flow / Change in cash | - | - | -6.15 Billion | -1.29 Billion | 310 Million | -3.93 Billion |
| Free Cash Flow | - | - | 4.86 Billion | 934 Million | 418 Million | 364 Million |
BIOGEN
PARKERAC
688611
CGLO
STEP2COR
002989